Carvajal A, García del Pozo J, Martín Arias L H, Martín de Diego I, Rueda A M, Caro-Patón T, Alvarez Requejo A
Centro Regional de Farmacovigilancia, Universidad de Valladolid.
Med Clin (Barc). 1997 Sep 13;109(8):281-3.
Data from different sources have proved an infrautilization of opioid analgesics in Spain. A descriptive study has been conducted in order to know the utilization of these drugs and changes in the pattern of use in the last few years.
To know the consume of narcotic analgesic drugs, N02A group of the Anatomic Therapeutic Classification, a search was developed in the ECOM database from the Spanish Ministry of Health. This database contains information of drug preparations prescribed throughout the National Health Care System.
The consumption of opioid analgesics in Spain has been multiplied by 5.2 during this period. It has increased from 94.7 defined daily dose per 1,000,000 inhabitants in 1985 to 489.4 in 1994. The most consumed drug in 1994 was dihydrocodeine, followed by tramadol. The number of defined daily dose per inhabitant and day of parenteral administration have decreased during the last years.
Availability of new analgesic opioid drugs with better pharmacokinetic profiles has contributed to an increase of their consume in Spain.
来自不同来源的数据已证明西班牙存在阿片类镇痛药使用不足的情况。为了解这些药物的使用情况以及过去几年使用模式的变化,开展了一项描述性研究。
为了解麻醉性镇痛药的消费情况,在西班牙卫生部的ECOM数据库中对解剖治疗学分类中的N02A组进行了检索。该数据库包含整个国家医疗保健系统中所开药物制剂的信息。
在此期间,西班牙阿片类镇痛药的消费量增长了5.2倍。从1985年每百万居民94.7限定日剂量增加到1994年的489.4。1994年消费最多的药物是二氢可待因,其次是曲马多。在过去几年中,每居民每日肠胃外给药的限定日剂量数量有所下降。
具有更好药代动力学特征的新型阿片类镇痛药物的可获得性促使其在西班牙的消费量增加。